Evidence map›Paper›PMID 33989745›Full record

ArticleBrain, behavior, and immunity2021

Environmental activation of a hypothalamic BDNF-adipocyte IL-15 axis regulates adipose-natural killer cells.

Stephen M Bergin, Run Xiao, Wei Huang, C Ryan T Judd, Xianglan Liu, Anthony G Mansour, Nicholas Queen, Kyle J Widstrom, Michael A Caligiuri, Lei Cao

Open access · greenAbstract read
In one paragraph

Article in Brain, behavior, and immunity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Upregulation ofGut microbes · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Stephen M BerginThe Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, Columbus, OH 43210, United States; Medical Scientist Training Program, College of Medicine, The Ohio State University, Columbus, OH 43210, United States.
Run XiaoThe Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, Columbus, OH 43210, United States; Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH 43210, United States.
Wei HuangThe Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, Columbus, OH 43210, United States; Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH 43210, United States.
C Ryan T JuddThe Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, Columbus, OH 43210, United States.
Xianglan LiuThe Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, Columbus, OH 43210, United States; Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH 43210, United States.
Anthony G MansourDepartment of Hematological Malignancies and Stem Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, 91010, United States.
Nicholas QueenThe Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, Columbus, OH 43210, United States; Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH 43210, United States.
Kyle J WidstromThe Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, Columbus, OH 43210, United States; Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH 43210, United States.
Michael A CaligiuriDepartment of Hematological Malignancies and Stem Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, 91010, United States. Electronic address: mcaligiuri@coh.org.
Lei CaoThe Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, Columbus, OH 43210, United States; Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH 43210, United States. Electronic address: lei.cao@osumc.edu.
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USCity Of Hope National Medical Center · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3M
The Tumor Microenvironmental Barrier to Effective Viral OncolysisP01CA163205 · NCI · OHIO STATE UNIVERSITY · PI Xiaokui Mo · 2013 to 2026
$26.0M
Human natural killer cells: Advancing biology and clinical applicationsR35CA210087 · NCI · OHIO STATE UNIVERSITY · PI MICHAEL A CALIGIURI · 2017 to 2026
$8.3M
IL-15--CHARACTERIZATION THROUGH EXPERIMENTAL IMMUNOLOGYR01CA068458 · NCI · ROSWELL PARK CANCER INSTITUTE · PI CALIGIURI, MICHAEL A, YU, JIANHUA · 1996 to 2019
$4.5M
Cancer Prevention and Treatment by Activation of a Brain-Adipocyte AxisR01CA166590 · NCI · OHIO STATE UNIVERSITY · PI CAO, LEI · 2013 to 2022
$3.4M
Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer PreventionR01CA185301 · NCI · OHIO STATE UNIVERSITY · PI CALIGIURI, MICHAEL A, YU, JIANHUA · 2015 to 2019
$1.8M
The role of hypothalamic-sympathoneural-adipocyte axis in healthy agingR01AG041250 · NIA · OHIO STATE UNIVERSITY · PI CAO, LEI · 2013 to 2017
$1.6M
IL-15 characterization through experimental immunologyR37CA068458 · NCI · OHIO STATE UNIVERSITY · PI CALIGIURI, MICHAEL A · 2010 to 2014
$1.4M
Identifying brain mediators distinguishing eustress and distress impact on cancerR01CA163640 · NCI · OHIO STATE UNIVERSITY · PI CAO, LEI · 2013 to 2017
$1.2M
The role of hypothalamic-sympathoneural-adipocyte axis in healthy agingR56AG041250 · NIA · OHIO STATE UNIVERSITY · PI CAO, LEI · 2019 to 2019
$390k
Modulating cancer progression by adipogenic human adenovirus type 36R21CA178227 · NCI · OHIO STATE UNIVERSITY · PI CAO, LEI · 2013 to 2014
$375k
NCI NIH HHS P01 CA163205NCI NIH HHS P30 CA016058NCI NIH HHS R01 CA068458NCI NIH HHS R01 CA163640NCI NIH HHS R01 CA166590NCI NIH HHS R01 CA185301NCI NIH HHS R21 CA178227NCI NIH HHS R35 CA210087NCI NIH HHS R37 CA068458NIA NIH HHS R01 AG041250NIA NIH HHS R56 AG041250
6 · The paper itself

Abstract

Physical and social environments influence immune homeostasis within adipose tissue, yet the mechanisms remain poorly defined. We report that an enriched environment (EE) housing modulates the immune cell population in white adipose tissue of mice including an increase in the abundance of natural killer (NK) cells. EE upregulates the expression of IL-15 and its receptor IL-15Rα specifically within mature adipocytes. Mechanistically, we show that hypothalamic brain-derived neurotrophic factor (BDNF) upregulates IL-15 production in adipocytes via sympathetic β-adrenergic signaling. Overexpressing BDNF mediated by recombinant adeno-associated virus (rAAV) vector in the hypothalamus expands adipose NK cells. Conversely, inhibition of hypothalamic BDNF signaling via gene transfer of a dominant negative TrkB receptor suppresses adipose NK cells. In white adipose tissue, overexpression of IL-15 using an adipocyte-specific rAAV vector stimulates adipose NK cells and inhibits the progression of subcutaneous melanoma, whereas local IL-15 knockdown blocks the EE effect. These results suggest that bio-behavioral factors regulate adipose NK cells via a hypothalamic BDNF-sympathoneural-adipocyte IL-15 axis. Targeting this pathway may have therapeutic significance for cancer.

Indexed as

AdipocytesBrain-Derived Neurotrophic FactorInterleukin-15Killer Cells, NaturalAdipose TissueAnimalsHypothalamusMiceMice, Inbred C57BLBrain-Derived Neurotrophic FactorInterleukin-15Adipose tissueBDNFEnvironmental enrichmentHypothalamusIL-15NK cellβ-Adrenergic signaling, AAV, cancer

Identifiers

PMID33989745
PMCPMC8493653
OpenAlexW3163442036

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.